Breaking News

inVentiv Health Clinical Names Late-Stage EVP

By Kristin Brooks | February 5, 2014

Okamoto brings management and outcomes research expertise

Lynn Okamoto, Pharm.D., has been named executive vice president of the Late Stage Business Unit at inVentiv Health Clinical, effective March 3rd. Dr. Okamoto has experience as global manager with expertise in healthcare analytics and health outcomes research. She joins the company from Evidera, where she served as senior vice president and senior research scientist of Health Economics & Epidemiology. Previously she led the Intelligent Health Repository at NDC Health.
"inVentiv Health was built for this new marketplace, with the broadest range of convergent services in the industry," said Raymond Hill, president inVentiv Health Clinical. "Our Late Stage Clinical group works seamlessly with inVentiv experts in study design and implementation, market access, reimbursement, stakeholder relations and scientific communications to anticipate the questions that will be asked in the marketplace and assure our clients are armed with effective answers."
blog comments powered by Disqus
  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • The Search &  Rescue Mission for Data Integrity

    The Search & Rescue Mission for Data Integrity

    Mike Jovanis, Vice President of Vault QualityDocs, Veeva Systems||October 11, 2016
    Cloud technology is essential for success